GAPDH and hepatocellular carcinoma: Among the four selected genes, the RT-qPCR assay determining cfDII-integrity and -fragmentation for ALU and GAPDH have shown promising utility as an early biomarker for hepatocarcinogenesis by differentiating HCC from CLD.